Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Explosives detection dogs trained to identify cancer
dog's nose
Over 40,000 new cases of prostate cancer are diagnosed every year, making it the most common cancer in UK men (file photo).
Dogs detect prostate cancer with over 90 per cent accuracy

A pair of German shepherd dogs have been trained to detect prostate cancer with well over 90 per cent accuracy, according to an Italian study.

The two explosion detection dogs were trained to recognise volatile organic compounds linked to prostate cancer in urine samples.

More than 900 patients' samples were involved in the study, of whom 362 had cancer (ranging from low risk to metastatic) and 540 were healthy controls.

Findings published in the Journal of Urology demonstrate remarkable accuracy in the dogs' ability to identify cancer.

Over 40,000 new cases of prostate cancer are diagnosed every year, making it the most common cancer in UK men.

Current tests used are most commonly blood tests, physical examination and biopsies.

Results from the blood test, which measures the level of prostate-specific antigens (PSA), can be unreliable as a raised PSA can also be due to non-cancerous prostate growth, urinary tract infections or prostate inflammation, as well as cancer. Raised PSA can therefore lead to unnecessary tests and treatment.

Claire Guest, co-founder of the UK charity Medical Detection Dogs, said the results of the Italian study were "spectacular". The charity's own research has found 93 per cent accuracy in dogs' ability to recognise prostate cancer.

Writing in the Journal of Urology, researchers say further work is needed to determine how valuable this ability will be in identifying prostate cancer in practice.

Read the full study: http://www.jurology.com/article/S0022-5347%2814%2904573-X/abstract

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.